| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |